ClinicalTrials.Veeva

Menu

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

National Cancer Institute (NCI) logo

National Cancer Institute (NCI)

Status

Completed

Conditions

Healthy
Retinal Degeneration
Skin Diseases
Virus Diseases
Muscular Dystrophy

Study type

Observational

Funder types

NIH

Identifiers

NCT00001164
78-C-0099
780099

Details and patient eligibility

About

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Full description

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible.

Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases.

Volunteers without skin diseases are eligible, except children.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems